Andere Kunden interessierten sich auch für
![Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases]( "Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases")
Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases93,99 €![Infection Control in the Intensive Care Unit]( "Infection Control in the Intensive Care Unit")
Infection Control in the Intensive Care Unit110,99 €![The Pathogenic Enteric Protozoa:]( "The Pathogenic Enteric Protozoa:")
The Pathogenic Enteric Protozoa:83,99 €![New and Evolving Infections of the 21st Century]( "New and Evolving Infections of the 21st Century")
New and Evolving Infections of the 21st Century147,99 €![Emerging Infections in Asia]( "Emerging Infections in Asia")
Emerging Infections in Asia37,99 €![Emerging Issues and Controversies in Infectious Disease]( "Emerging Issues and Controversies in Infectious Disease")
Emerging Issues and Controversies in Infectious Disease147,99 €![Pathogenesis of Wound and Biomaterial-Associated Infections]( "Pathogenesis of Wound and Biomaterial-Associated Infections")
Pathogenesis of Wound and Biomaterial-Associated Infections83,99 €
Biofilms in Infection and Disease Control: A Healthcare Handbook outlines the scientific evidence and rationale for the prevention of infection, the role biofilms play in infection control, and the issues concerning their resistance to antimicrobials. This book provides practical guidance for healthcare and infection control professionals, as well as students, for preventing and controlling infection.
Biofilms are the most common mode of bacterial growth in nature. Highly resistant to antibiotics and antimicrobials, biofilms are the source of more than 65 percent of health care associated infections (HCAI), which, according to the WHO, affect 1.4 million people annually. Biofilms are involved in 80 percent of all microbial infections in the body, including those associated with medical devices such as catheters, endotracheal tubes, joint prostheses, and heart valves. Biofilms are also the principle causes of infections of the middle-ear, dental caries, gingivitis, prostatitis and cystic fibrosis. Importantly, biofilms also significantly delay wound healing and reduce antimicrobial efficiency in at-risk or infected skin wounds.
Biofilms are the most common mode of bacterial growth in nature. Highly resistant to antibiotics and antimicrobials, biofilms are the source of more than 65 percent of health care associated infections (HCAI), which, according to the WHO, affect 1.4 million people annually. Biofilms are involved in 80 percent of all microbial infections in the body, including those associated with medical devices such as catheters, endotracheal tubes, joint prostheses, and heart valves. Biofilms are also the principle causes of infections of the middle-ear, dental caries, gingivitis, prostatitis and cystic fibrosis. Importantly, biofilms also significantly delay wound healing and reduce antimicrobial efficiency in at-risk or infected skin wounds.